Biochem Pharmaceutical Industries Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Biochem Pharma. Inds

Based on:

M-Cap below 100cr DeciZen not available

Biochem Pharmaceutical Industries stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Biochem Pharma. Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
ROCE % 43.6%37%24.3%23%61.1%30.2%39.3%25.7%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 224239249227268269318365365
Sales YoY Gr.-6.8%4%-8.7%17.9%0.4%18.3%14.5%-
Adj EPS 19.719.714.910.526.710.122.116.80
YoY Gr.-0.2%-24.3%-29.9%154.8%-62.3%119.8%-24.1%-
BVPS (₹) 59.769.424.634.637.846.165.6780
Adj Net
Profit
14.814.811.27.8207.516.612.60
Cash Flow from Ops. 014.324.9-0.6-712.510.917.2-
Debt/CF from Ops. 01.52.6-82.6-1.12.83.11.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA7.9%10.8%14.5%
Adj EPS NA2.4%-14.3%-24.1%
BVPSNA26%27.3%18.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
Return on
Equity %
30.929.631.835.473.623.939.623.40
Op. Profit
Mgn %
10.79.798.613.36.77.76.8NAN
Net Profit
Mgn %
6.66.24.53.57.52.85.23.50
Debt to
Equity
0.30.43.520.310.70.6-
Working Cap
Days
01301191381191271231130
Cash Conv.
Cycle
0788195575143470

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Biochem Pharmaceutical Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 365 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 51 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.2

Management X-Ray of Biochem Pharma. Inds:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Biochem Pharma. Inds - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Biochem Pharma. Inds

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Sales224.11239.29248.89227.36268.04269.12318.38364.61
Operating Expenses 200.09216.10226.85207.75232.40251.14293.95339.89
Manufacturing Costs3.193.483.503.7222.9826.9226.3925.79
Material Costs146.03154.17164.52141.74147.86160.08194.16232.74
Employee Cost 28.3034.0121.4627.7528.3529.993440.47
Other Costs 22.5724.4437.3834.5433.2134.1639.4040.89
Operating Profit 24.0323.2022.0419.6235.6517.9824.4324.72
Operating Profit Margin (%) 10.7%9.7%8.9%8.6%13.3%6.7%7.7%6.8%
Other Income 1.592.131.472.771.390.9812
Interest 1.981.223.156.624.843.854.054.54
Depreciation 0.681.102.862.542.303.07-4.572.17
Exceptional Items 00-1.66-1.44000-2.11
Profit Before Tax 22.972315.8411.7829.8912.0425.9517.90
Tax 8.187.675.733.879.894.529.386.80
Profit After Tax 14.7915.3210.107.91207.5116.5711.10
PAT Margin (%) 6.6%6.4%4.1%3.5%7.5%2.8%5.2%3.0%
Adjusted EPS (₹)19.720.413.510.626.710.022.114.8
Dividend Payout Ratio (%)63%61%371%5%75%15%9%14%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16

Equity and Liabilities

Shareholders Fund 47.7252.0718.4525.9228.3734.5749.1758.47
Share Capital 7.507.507.507.507.507.507.507.50
Reserves 40.2244.5710.9518.4220.8727.0741.6750.97
Minority Interest00000000
Debt12.3721.7163.862.817.4334.8434.2033
Long Term Debt12.3721.715700333333
Short Term Debt006.862.817.431.841.200
Trade Payables16.4418.8817.9323.5738.1932.1238.7542.09
Others Liabilities 38.0118.9828.7566.1233.9638.1440.1535
Total Liabilities 114.53111.65128.99118.43107.95139.67162.27168.56

Fixed Assets

Gross Block6.6824.8725.8826.1426.2546.6447.0547.95
Accumulated Depreciation2.483.566.138.4310.5813.418.9810.77
Net Fixed Assets 4.2021.3119.7517.7015.6733.2338.0737.18
CWIP 10.777.4117.3600000.66
Investments 3.931.95000000
Inventories24.0227.1534.0752.2841.9737.6341.0738.43
Trade Receivables45.5347.7852.5337.0943.8342.3848.8266.98
Cash Equivalents 0.771.372.397.871.660.625.9913.62
Others Assets 25.314.682.893.484.8225.8128.3211.69
Total Assets 114.53111.65128.99118.43107.95139.67162.27168.56

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Cash Flow From Operating Activity 014.3324.94-0.63-6.9612.5410.8817.21
PBT 02317.5011.7829.8912.0425.9517.90
Adjustment 00.356.469.318.186.770.167.55
Changes in Working Capital 0-1.76.96-16.28-35.66-2.25-8.5-1.05
Tax Paid 0-7.31-5.97-5.44-9.37-4.02-6.73-7.19
Cash Flow From Investing Activity 0-11.87-9.9319.581.04-19.760.39-0.43
Capex 0-14.85-11.5518.39-0.26-20.67-0.42-2.05
Net Investments 02.65000000
Others 00.331.621.191.310.900.811.62
Cash Flow From Financing Activity 0-2.64-12.34-13.48-0.276.16-5.90-9.15
Net Proceeds from Shares 00000000
Net Proceeds from Borrowing 00000000
Interest Paid 0-1.01-2.90-6.32-4.45-3.70-3.93-4.34
Dividend Paid 0-10.97-51.580-0.38-15-1.13-3
Others 09.3442.15-7.164.5524.87-0.84-1.81
Net Cash Flow 0-0.182.685.47-6.19-1.065.377.63

Finance Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Ratios
ROE (%)3331.6428.6635.6673.6723.8839.5820.62
ROCE (%)43.633724.3322.9661.0530.239.2725.67
Asset Turnover Ratio1.982.132.161.942.482.282.22.3
PAT to CFO Conversion(x)00.942.47-0.08-0.351.670.661.55
Working Capital Days
Receivable Days7371706853565056
Inventory Days3939436661524338
Payable Days4142415376806763

Biochem Pharmaceutical Industries Ltd Stock News

Biochem Pharmaceutical Industries Ltd FAQs

The current trading price of Biochem Pharma. Inds on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Biochem Pharma. Inds stood at ₹0.00.
The latest P/E ratio of Biochem Pharma. Inds as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Biochem Pharma. Inds as of 31-Dec-1969 is 0.00.
The 52-week high of Biochem Pharma. Inds is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biochem Pharma. Inds is ₹364.6 ( Cr.) .

About Biochem Pharmaceutical Industries Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×